An Outcome Analysis of Primary Membranous Nephropathy

Recruiting Observational Study
Membranous Nephropathy
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
500 (estimated)
Sponsor
Mario Negri Institute for Pharmacological Research · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This is an observational study intended to track the course of the primary membranous nephropathy disease in real-world clinical practice. The study will primarily assess the long-term outcomes of patients with primary membranous nephropathy in the context of advances in treatment options.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults (≥18 years old) on the day of signing informed consent. * Diagnosis of primary membranous nephropathy * Nephrotic syndrome (proteinuria \>3.5 g/24 hours) * Written informed consent to the use of recorded data for research purposes. Exclusion Criteria: * Legal incapaci…
Contacts

Matias Trillini, MD

+3903545351

matias.trillini@marionegri.it

CONTACT

Piero L Ruggenenti, MD

pruggenenti@asst-pg23.it

CONTACT